BioLineRx (BLRX) Receivables (2022 - 2025)
BioLineRx (BLRX) recorded quarterly Receivables of $456000.0 in Q4 2025, up 62.28% quarter-over-quarter from $281000.0 in Q2 2025, and down 88.47% on a YoY basis from $4.0 million in Q4 2024.
BioLineRx (BLRX) Receivables (2022 - 2025) Analysis & Trends
BioLineRx's Receivables history runs 4 years deep, the most recent figure standing at $456000.0 for Q4 2025.
- In Q4 2025, Receivables fell 88.47% year-over-year to $456000.0; the TTM figure through Dec 2025 stood at $456000.0 (down 88.47% YoY), while the FY2025 annual figure was $456000.0, down 88.47% from the prior year.
- Receivables was $456000.0 for Q4 2025 at BioLineRx, up from $281000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $4.0 million in Q3 2024 to a low of $281000.0 in Q2 2025.
- Historically, Receivables has averaged $2.2 million across 4 years, with a median of $1.9 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Receivables surged 232.83% in 2024, then plunged 92.67% in 2025.
- A 4-year view of Receivables shows it stood at $721000.0 in 2022, then jumped by 64.77% to $1.2 million in 2023, then soared by 232.83% to $4.0 million in 2024, then slumped by 88.47% to $456000.0 in 2025.
- The last three Receivables figures came in at $456000.0 (Q4 2025), $281000.0 (Q2 2025), and $1.9 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BioLineRx | 227.63 Mn | 211.90 Mn | 154,000.00 | 456,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 456,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 1.92 Mn |
| Dec 31, 2024 | 3.95 Mn |
| Sep 30, 2024 | 3.96 Mn |
| Jun 30, 2024 | 3.84 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 721,000.00 |